HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

McNeil Recalls Cut J&J's Profits, Draw U.S. Attorney's Subpoena

This article was originally published in The Tan Sheet

Executive Summary

Investment analysts are confident in Johnson & Johnson's long-term viability even though recalls of OTC drugs and the temporary closure of the facility where the products were made prompted the firm to slash full-year profits estimates and triggered a federal investigation

You may also be interested in...



J&J Separates U.S. OTCs In "Unorthodox" Reorg To Get McNeil Back On Track

As the new head of Johnson & Johnson's beleaguered U.S. OTC business, Pat Mutchler takes on the burden of restoring the firm's reputation and manufacturing quality.

J&J Consumer Unit Underperforms In Q3 As Recall Aftereffects Linger

Johnson & Johnson's consumer business missed revised analyst estimates and dragged down overall sales in the third quarter of what can only be called a lost year for the unit

J&J/McNeil Done With Post-Recall Personnel Changes - CEO Weldon

Johnson & Johnson has finished culling its ranks of employees responsible for quality control lapses that led to extensive OTC recalls, according to CEO William Weldon.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS135546

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel